The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Adenosine Triphosphate (ATP) Assays Market Projected To Reach By 2030?
The adenosine triphosphate (atp) assays market has seen considerable expansion in recent years. It is projected to increase from $2.19 billion in 2025 to $2.45 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.6%. This historical growth can be linked to elements such as the constrained availability of high-sensitivity ATP assay kits, the reliance on traditional biochemical assays, expanding pharmaceutical research endeavors, the increasing integration of molecular biology techniques, and the rising demand for food safety and environmental monitoring.
The adenosine triphosphate (atp) assays market is anticipated to experience substantial expansion over the upcoming years, with its size projected to reach $3.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This increase during the forecast period is primarily driven by the evolution of high-throughput atp assay platforms, the growing integration with automated laboratory instruments, expanding applications in clinical diagnostics and personalized medicine, the enlargement of biotechnology research and drug development efforts, and advancements in fluorescent and luminescent assay technologies. Noteworthy trends for this period encompass the greater adoption of atp assays in drug discovery, an increasing utilization of cell-based assays for viability and cytotoxicity testing, the broadened use of atp assays in food safety and environmental testing, a rising demand for luminometric and enzymatic atp assays, and a strengthened focus on assay sensitivity, accuracy, and standardization.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Adenosine Triphosphate (ATP) Assays Market?
The rising frequency of cancer, chronic, and infectious diseases is projected to boost the adenosine triphosphate (ATP) assay market in the future. Cancer is characterized by uncontrolled cell division that can invade and harm surrounding tissues and potentially spread throughout the body. Chronic diseases are stable, slowly progressing conditions that persist over a long period. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals. ATP assays offer a valuable diagnostic tool for these conditions by assessing cellular viability, detecting microbial contamination, evaluating treatment efficacy, and monitoring metabolic and mitochondrial dysfunction. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, forecast that new cancer cases would exceed 35 million by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Furthermore, data published by the European Centre for Disease Prevention and Control (ECDC), a Sweden-based European Union agency, in November 2024, indicated that 112,883 HIV diagnoses were reported in 2023 across 47 out of 53 countries in the region, with 24,731 cases recorded in the European Union/European Economic Area (EU/EEA). The overall crude rate of HIV diagnoses reached 12.7 per 100,000 population, reflecting a 2.4% increase compared to the 12.4 per 100,000 rate observed in 2022. Therefore, the growing incidence of cancer, chronic, and infectious diseases is driving the adenosine triphosphate (ATP) assay market.
What Are The Key Segment Divisions In The Adenosine Triphosphate (ATP) Assays Market Segment Structure?
The adenosine triphosphate (atp) assays market covered in this report is segmented –
1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types
2) By Component: Consumables And Accessories, Instruments
3) By Application: Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions
Subsegments:
1) By Luminometric ATP Assays: Luciferase-Based Assays, Chemiluminescent Assays
2) By Enzymatic ATP Assays: Kinase-Based Assays, ATPase Activity Assays
3) By Bioluminescence Resonance Energy Transfer (BRET) ATP Assays: BRET For Protein-Protein Interactions, BRET For Drug Discovery
4) By Cell-Based ATP Assays: Live-Cell ATP Measurement, Cell Viability Assays
5) By Other Types: Fluorescent ATP Assays, Spectrophotometric ATP Assays
Which Trends Are Influencing Demand In The Adenosine Triphosphate (ATP) Assays Market?
Companies operating within the adenosine triphosphate (ATP) assays market are concentrating on developing technologically advanced kinase testing platforms to provide highly sensitive assays. A kinase testing platform is a specialized system designed to evaluate kinase activity in biological samples, assisting drug discovery and development by offering insights into kinase function and inhibition. For instance, in April 2024, Reaction Biology, a US-based biotechnology company, launched the HotSpotTM ATP-Max KinomeScreen, an advanced assay engineered for high-throughput kinase screening, featuring enhanced sensitivity that permits testing at 1 mM ATP levels. This innovative platform utilizes a gold standard filter binding radiometric assay to assess kinase activity across the industry’s most extensive array of kinase targets. By delivering physiologically relevant data, the HotSpotTM ATP-Max KinomeScreen enables researchers to discover more potent and specific kinase inhibitors, thereby strengthening drug discovery initiatives and facilitating the development of targeted therapies for numerous diseases, particularly cancer.
Which Organizations Are Engaged In The Adenosine Triphosphate (ATP) Assays Market?
Major companies operating in the adenosine triphosphate (atp) assays market are Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.
Get The Full Adenosine Triphosphate (ATP) Assays Market Report:
Which Region Is The Largest In The Adenosine Triphosphate (ATP) Assays Market?
North America was the largest region in the adenosine triphosphate (ATP) assays market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Adenosine Triphosphate (ATP) Assays Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Adenosine Triphosphate (ATP) Assays Market 2026, By The Business Research Company
In Vitro Diagnostics Enzymes Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report
Protein Assays Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report
Cell Based Assays Market Report 2026
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model